Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines. - Wikidata - wikimedia - TriplyDB

Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines.

Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines.

http://www.wikidata.org/entity/Q38230278

about

Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential Current and future targeted therapies for non-small-cell lung cancers with aberrant EGF receptors The efficacy and safety of immunotherapy in patients with advanced NSCLC: a systematic review and meta-analysis.CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer.Immunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung Cancer The MAGE protein family and cancer.A general strategy to optimize immunogenicity of HLA-B*0702 restricted cryptic peptides from tumor associated antigens: Design of universal neo-antigen like tumor vaccines for HLA-B*0702 positive patients.Melanoma antigen A12 regulates cell cycle via tumor suppressor p21 expression.Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.

P2860

Q26769884-36F8D299-455E-4E8D-92FF-73600FD66887 Q28086768-7EF0A9F0-DD62-4A1D-841D-9F8305E56387 Q33434828-D2A5D0F4-B93C-4406-A98A-49EC64759AF3 Q34490460-D11F6D0A-2072-44F2-9F02-3258BE2CEE0F Q37606871-D0FCE1CC-6A54-4D18-AF47-6B081EFCD7DF Q38581531-31B76CA3-62D1-4718-8FF9-A62770DA12C7 Q42031722-DA7D18FD-4D64-4B2F-9A11-4D26B9F27F3F Q42366622-A31AF6C0-252C-4279-AF09-D98B2BCB8969 Q48334085-F33FD6C6-FE80-4E5B-B2B5-546B0F05CFB1

P2860

Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines.

http://www.wikidata.org/entity/Q38230278

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines.

@en

type

label

Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines.

@en

prefLabel

Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines.

@en

P1433

Q38230278-4ECFC6B5-1E84-4090-9336-E737B435BE7E

P1476

Q38230278-7E3B67F5-7FD7-4E9F-9F72-0A6F4A850749

P2093

Q38230278-C143824C-B4ED-492A-8DB1-5E0D5D489326

Q38230278-DF5106EF-65AD-4E5B-A94B-4E3B9963F842

P2860

Q38230278-156A264F-D8FB-4FB9-9A41-683F5A155AD2

Q38230278-195F2F0C-1238-4FD6-A228-B64AA7340728

Q38230278-2279830C-71B3-4C54-858D-A05B118080B6

Q38230278-30C5E2F2-7DCA-429F-B300-9A3D153C5E47

Q38230278-47EF8372-BF77-4AD4-A4D7-4E91731BB2CA

Q38230278-6130F932-9113-44E0-865A-0BC6DAEF1509

Q38230278-7D1708F8-8796-42D6-A819-3FD64FF833B8

Q38230278-84CEFAFC-CDC8-4483-BCAA-76E95686C330

Q38230278-8969BBCF-5DA4-4FD2-8629-85A63AA11FEB

Q38230278-8E44D1C9-4F6B-44DE-8513-EE0D46805A30

P2888

Q38230278-369B393F-A2CB-425D-AC67-DA824278FE4C

P304

Q38230278-19E3C309-655A-4A53-A7B8-16C6DF753E64

P31

Q38230278-DE9C190F-E54E-4EFE-B616-C50DF0B244C9

P356

Q38230278-3023121A-5D9A-4B38-9347-7C85DD42ABEA

P433

Q38230278-A48B9A0C-B47C-4252-BEBD-F980FC71AFCE

P478

Q38230278-A73C8DEE-848E-4F98-B6D6-3AE4B595215B

P50

Q38230278-FC3DD5A2-3715-41E5-8528-2EFABC6965D9

P577

Q38230278-48EC5419-64B3-4E32-9EBB-C17CC824456A

P6179

Q38230278-D73B7CC1-1587-483D-AB4A-0222E853E298

P698

Q38230278-337C044E-BC9A-4971-9CB9-DB54F83365E4

P921

Q38230278-6DC8CAA9-A1F5-44ED-B591-92522B566637

P356

S11912-014-0400-6

P1433

Current Oncology Reports

P1476

Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines.

@en

P2093

Brian Hunis

http://www.w3.org/2001/XMLSchema#string

Luis E Raez

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Lung cancer vaccines

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer

Therapeutic vaccination with epidermal growth factor (EGF) in advanced lung cancer: analysis of pooled data from three clinical trials.

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer

Transforming growth factor beta (TGF-beta) and inflammation in cancer.

P2888

s11912-014-0400-6

P304

400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-014-0400-6

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046416668

http://www.w3.org/2001/XMLSchema#string

P698

25030654

http://www.w3.org/2001/XMLSchema#string

P921